The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.
about
Oxidative Stress Signaling in Alzheimers DiseaseThe role of titin and extracellular matrix remodelling in heart failure with preserved ejection fractionThe growing problem of obesity: mechanisms, consequences, and therapeutic approachesInflammation and Alzheimer's diseaseElevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesionsCommercial processed soy-based food product contains glycated and glycoxidated lunasin proteoformsBeneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanismsElectrospray low energy CID and MALDI PSD fragmentations of protonated sulfinamide cross-linked peptides.Production of brominating intermediates by myeloperoxidase. A transhalogenation pathway for generating mutagenic nucleobases during inflammation.Paradoxical impact of antioxidants on post-Amadori glycoxidation: Counterintuitive increase in the yields of pentosidine and Nepsilon-carboxymethyllysine using a novel multifunctional pyridoxamine derivative.Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein.Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside.The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculatureModifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathwayATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.Quantification and significance of protein oxidation in biological samples.The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitorsA glutathione-based system for defense against carbonyl stress in Haemophilus influenzae.Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins.Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.Central role of RAGE-dependent neointimal expansion in arterial restenosis.Modifications of proteins by polyunsaturated fatty acid peroxidation productsWhole tumor antigen vaccines.Influence of nonenzymatic posttranslational modifications on constitution, oligomerization and receptor binding of S100A12Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation.Posttranslationally modified proteins as mediators of sustained intestinal inflammation.The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's diseaseRAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes.Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathyAdvanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot StudGlycation and insulin resistance: novel mechanisms and unique targets?Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.RAGE and its ligands: a lasting memory in diabetic complications?Effect of high advanced glycation end-product diet on pulmonary inflammatory response and pulmonary function following gastric aspirationModulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidantsAnti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice.RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice.Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway.
P2860
Q22241327-8C32DACB-742D-47EC-92C9-19C8D2584C1BQ26765101-FCD6F17B-F411-49A7-B4F1-0AAF2425641BQ26851397-BA99750E-E709-4418-B431-1403A902B140Q28138617-7D945109-24C0-4C04-A572-A812DBA95269Q28344995-1AFB5456-6F6C-4277-95AE-E2BB9C934DCFQ28834062-A2FBAD3D-62F3-4F6F-B418-AEC2F9F7A3DCQ30360076-399300D6-0FCF-4D33-A34D-C2131A88C491Q31073231-59DA1C16-037C-4D7A-8F89-4B256A68394AQ31628322-E36B44A4-A4BC-4402-B0C1-F6D49D909B68Q33187854-C72698AD-E301-48BE-B53A-955726082260Q33195740-A37FEE4B-39F9-4C83-8759-A73F252AFD54Q33222417-10B0A287-CE7F-478B-BDEA-CD7CA90E055AQ33724878-24F74D1B-26B9-43D1-BC13-7ED89FAF0956Q33822512-87261B23-7720-41FD-B1E5-01938E8AE4A0Q33897803-CE3E3F38-B3C5-4E51-920B-D8E86FBFB5B9Q34112680-95C00EBF-A7E5-4896-A34D-842748B3C634Q34119149-0071BCE0-AFCB-4C18-B3BC-8A2ADB90C30CQ34178582-8A05FDDA-9A48-4456-975B-00B737BFB682Q34360209-D039B338-AA64-42BD-96D1-4D5BBFC5C22BQ34528130-1D998E14-0CAA-4858-9BCC-F3AFC5834E83Q34774357-4658DB95-2A66-46FE-8DF9-D91DB2E4F17CQ34890522-DF2364A9-C1DE-4C21-A492-60209A36709AQ34968643-0314C3A4-7F66-40B7-B2FC-763E021FA8EEQ35058235-C181F3FC-2B39-4966-9EBE-2E9716F9C1FDQ35451921-31FF26AF-E811-4A29-9FC2-A1BFF87F515BQ35583145-81B086C7-5827-4AF7-9334-E92C1B2ECE4BQ35607249-791D16DD-4181-413A-98F2-7465F7D609C2Q35621852-A352473D-23B8-48BC-863E-63D9801C7470Q35740332-4720ACFF-4913-4D5E-AEF2-26A0FB7EE510Q35746701-8AC8CA14-63FF-435A-9B93-05B23BC48A1FQ36069797-E25CA3F1-3BCD-42A4-8F8A-38C64C1BB998Q36104828-93DC7530-9FC4-4374-8E0C-A4CD3351DF47Q36115715-5404B146-DF0A-4C9F-AA49-C9A7ACBFE978Q36203962-07FA03A7-BD85-47D9-A19C-0ED4E10D7BECQ36320548-35FC6290-A159-4A79-AA97-840EDB3EDDA8Q36495940-FF7330FE-B9BC-4AED-B90D-01AE1F03C37BQ36511677-55C231C1-6BE1-4775-86FC-868E2602613FQ36610126-D24E13BE-C82E-41CA-98E4-35963E7F261FQ36635410-59D11740-6C91-495C-8E98-19282B0987FAQ36893819-19636873-9EDD-46E1-9F05-1675D4D91C28
P2860
The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The myeloperoxidase system of ...... ucts at sites of inflammation.
@ast
The myeloperoxidase system of ...... ucts at sites of inflammation.
@en
type
label
The myeloperoxidase system of ...... ucts at sites of inflammation.
@ast
The myeloperoxidase system of ...... ucts at sites of inflammation.
@en
prefLabel
The myeloperoxidase system of ...... ucts at sites of inflammation.
@ast
The myeloperoxidase system of ...... ucts at sites of inflammation.
@en
P2093
P2860
P356
P1476
The myeloperoxidase system of ...... ucts at sites of inflammation.
@en
P2093
J R Crowley
J R Requena
J W Heinecke
M M Anderson
S R Thorpe
P2860
P304
P356
10.1172/JCI3042
P407
P577
1999-07-01T00:00:00Z